537 related articles for article (PubMed ID: 8330440)
1. Thyroxine replacement therapy and circulating lipid concentrations.
Franklyn JA; Daykin J; Betteridge J; Hughes EA; Holder R; Jones SR; Sheppard MC
Clin Endocrinol (Oxf); 1993 May; 38(5):453-9. PubMed ID: 8330440
[TBL] [Abstract][Full Text] [Related]
2. Circulating lipids and minor abnormalities of thyroid function.
Parle JV; Franklyn JA; Cross KW; Jones SR; Sheppard MC
Clin Endocrinol (Oxf); 1992 Nov; 37(5):411-4. PubMed ID: 1486690
[TBL] [Abstract][Full Text] [Related]
3. Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy.
Miura S; Iitaka M; Yoshimura H; Kitahama S; Fukasawa N; Kawakami Y; Sakurai S; Urabe M; Sakatsume Y; Ito K
Intern Med; 1994 Jul; 33(7):413-7. PubMed ID: 7949641
[TBL] [Abstract][Full Text] [Related]
4. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
5. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?
Efstathiadou Z; Bitsis S; Milionis HJ; Kukuvitis A; Bairaktari ET; Elisaf MS; Tsatsoulis A
Eur J Endocrinol; 2001 Dec; 145(6):705-10. PubMed ID: 11720894
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.
Staub JJ; Althaus BU; Engler H; Ryff AS; Trabucco P; Marquardt K; Burckhardt D; Girard J; Weintraub BD
Am J Med; 1992 Jun; 92(6):631-42. PubMed ID: 1605145
[TBL] [Abstract][Full Text] [Related]
7. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B
J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
[TBL] [Abstract][Full Text] [Related]
8. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment.
Tzotzas T; Krassas GE; Konstantinidis T; Bougoulia M
Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458
[TBL] [Abstract][Full Text] [Related]
9. Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat.
Kabadi UM; Cech R
J Endocrinol Invest; 1997 Jun; 20(6):319-26. PubMed ID: 9294777
[TBL] [Abstract][Full Text] [Related]
10. Effect of the normalization of TSH and free T4 on lipid profile in a pediatric population with primary hypothyroidism.
Rivera-Hernández A; Rojas-Martínez R; Mendoza-Zubieta V; Balcázar-Hernández L
Andes Pediatr; 2021 Feb; 92(1):59-66. PubMed ID: 34106184
[TBL] [Abstract][Full Text] [Related]
11. High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism?
Michalopoulou G; Alevizaki M; Piperingos G; Mitsibounas D; Mantzos E; Adamopoulos P; Koutras DA
Eur J Endocrinol; 1998 Feb; 138(2):141-5. PubMed ID: 9506856
[TBL] [Abstract][Full Text] [Related]
12. Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified.
Bogner U; Arntz HR; Peters H; Schleusener H
Acta Endocrinol (Copenh); 1993 Mar; 128(3):202-6. PubMed ID: 8480467
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy.
Yildirimkaya M; Ozata M; Yilmaz K; Kilinç C; Gündoğan MA; Kutluay T
Endocr J; 1996 Dec; 43(6):731-6. PubMed ID: 9075615
[TBL] [Abstract][Full Text] [Related]
14. Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis.
Tagami T; Tamanaha T; Shimazu S; Honda K; Nanba K; Nomura H; Yoriko SU; Usui T; Shimatsu A; Naruse M
Endocr J; 2010; 57(3):253-8. PubMed ID: 20032565
[TBL] [Abstract][Full Text] [Related]
15. Increased oxidizability of low-density lipoproteins in hypothyroidism.
Diekman T; Demacker PN; Kastelein JJ; Stalenhoef AF; Wiersinga WM
J Clin Endocrinol Metab; 1998 May; 83(5):1752-5. PubMed ID: 9589687
[TBL] [Abstract][Full Text] [Related]
16. Effects of Thyrotropin on Peripheral Thyroid Hormone Metabolism and Serum Lipids.
Beukhof CM; Massolt ET; Visser TJ; Korevaar TIM; Medici M; de Herder WW; Roeters van Lennep JE; Mulder MT; de Rijke YB; Reiners C; Verburg FA; Peeters RP
Thyroid; 2018 Feb; 28(2):168-174. PubMed ID: 29316865
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism.
Fadeyev VV; Morgunova TB; Melnichenko GA; Dedov II
Hormones (Athens); 2010; 9(3):245-52. PubMed ID: 20688622
[TBL] [Abstract][Full Text] [Related]
19. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
Konno N; Morikawa K
J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
[TBL] [Abstract][Full Text] [Related]
20. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study.
Tognini S; Polini A; Pasqualetti G; Ursino S; Caraccio N; Ferdeghini M; Monzani F
Thyroid; 2012 Nov; 22(11):1096-103. PubMed ID: 23050788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
